Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cbiz (CBZ) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cbiz (CBZ) over the last 16 years, with Q3 2025 value amounting to $17.0 million.

  • Cbiz's Cash & Equivalents rose 147704.46% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year increase of 147704.46%. This contributed to the annual value of $13.8 million for FY2024, which is 7090.23% up from last year.
  • Cbiz's Cash & Equivalents amounted to $17.0 million in Q3 2025, which was up 147704.46% from $39.8 million recorded in Q2 2025.
  • Cbiz's Cash & Equivalents' 5-year high stood at $39.8 million during Q2 2025, with a 5-year trough of $558000.0 in Q1 2022.
  • For the 5-year period, Cbiz's Cash & Equivalents averaged around $6.6 million, with its median value being $3.7 million (2023).
  • As far as peak fluctuations go, Cbiz's Cash & Equivalents plummeted by 9687.57% in 2021, and later surged by 342987.59% in 2025.
  • Quarter analysis of 5 years shows Cbiz's Cash & Equivalents stood at $2.0 million in 2021, then skyrocketed by 135.2% to $4.7 million in 2022, then surged by 72.24% to $8.1 million in 2023, then surged by 70.9% to $13.8 million in 2024, then grew by 22.73% to $17.0 million in 2025.
  • Its Cash & Equivalents stands at $17.0 million for Q3 2025, versus $39.8 million for Q2 2025 and $8.8 million for Q1 2025.